-- Leon O Moulder Jr, Director, Chief Executive Officer, on April 28, 2026, executed a purchase for 60,000 shares in Zenas BioPharma (ZBIO) for $1,067,200. Following the Form 4 filing with the SEC, Moulder has control over a total of 2,246,122 common shares of the company, with 423,155 shares held directly and 1,822,967 controlled indirectly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1953926/000110465926051889/xslF345X05/tm2613154-1_4seq1.xml